Clinical significance of MYCN amplification in patients with high-risk neuroblastoma.
Pediatr Blood Cancer. 2018 May 24;:e27257
Authors: Lee JW, Son MH, Cho HW, Ma YE, Yoo KH, Sung KW, Koo HH
Abstract BACKGROUND: This study investigated the clinical significance of MYCN amplification within high-risk neuroblastoma (NB). METHODS: Medical records of 135 patients who were diagnosed with high-risk NB from 2004 to 2016 were reviewed.